Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3685-3693
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3685
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3685
No | Age | Sex | Procedure type | Procedure type | Liver disease | Liver cirrhosis | ICG-r15 | Operation time (minute) | Blood lost (mL) | POHS (days) | Tumor size | Pathological diagnosis | Complication |
1 | 57 | Male | S8 | Cranial | HBV | Yes | 4.80% | 148 | 150 | 10 | 1.3 | HCC | No |
2 | 66 | Female | S8 | Cranial | HBV | Yes | 6.20% | 174 | 200 | 7 | 2.2 | HCC | No |
3 | 30 | Female | S8d | Cranial | HBV | Yes | 2.40% | 98 | 20 | 8 | 1.2 | HCC | No |
4 | 48 | Male | S8 | Cranial | HBV | Yes | 5.30% | 180 | 200 | 7 | 1.8 | HCC | No |
5 | 67 | Female | S8 | Cranial | HBV | Yes | 4.40% | 160 | 100 | 9 | 1.2 | HCC | No |
6 | 49 | Male | S8 | Cranial | HBV | Yes | 4.10% | 116 | 100 | 7 | 3.5 | HCC | No |
7 | 42 | Male | S8d | Cranial | HBV | Yes | 4.20% | 190 | 100 | 8 | 1.0, 0.8 | EHE | No |
8 | 54 | Male | S8d | Cranial | HBV | Yes | 12.40% | 87 | 100 | 19 | 2.5 | HCC | No |
9 | 54 | Male | S8 | Cranial | HBV | Yes | 6.00% | 130 | 100 | 8 | 2.3 | HCC | Bile leakage |
10 | 75 | Male | S8 | Cranial | HBV | Yes | 6.30% | 200 | 100 | 8 | 5.3 | HCC | Bile leakage |
11 | 58 | Female | S8v | Cranial | HBV | Yes | 5.50% | 130 | 20 | 5 | 2.2 | EHE | No |
12 | 63 | Male | S8 | Cranial | - | No | 3.60% | 215 | 200 | 6 | 6.5 | ICC | Bile leakage |
13 | 23 | Male | S8 | Cranial | - | No | 6.70% | 155 | 200 | 8 | 1.4 | HCC | No |
14 | 82 | Male | S8 | Cranial | HBV | Yes | 7.80% | 149 | 200 | 12 | 1.5 | HCC | No |
15 | 66 | Male | S8 | Cranial | HBV | Yes | 6.40% | 155 | 200 | 7 | 2.9 | HCC | No |
16 | 53 | Male | S8 | Cranial | HBV | Yes | 4.60% | 210 | 300 | 8 | 2.5 | HCC | No |
17 | 61 | Female | S8 | Cranial | HBV | Yes | 21.98% | 95 | 50 | 10 | 5 | HCC | No |
18 | 66 | Female | S8 | Cranial | HBV | Yes | 2.40% | 60 | 100 | 8 | 3.5 | HCC | No |
19 | 67 | Female | S8 | Cranial | HBV | Yes | 6.90% | 56 | 10 | 7 | 3.8 | HCC | No |
20 | 66 | Male | S8 | Cranial | HBV | Yes | 7.50% | 183 | 100 | 12 | 2.2 | HCC | No |
21 | 51 | Male | S8 | Cranial | HBV | Yes | 18.60% | 289 | 150 | 12 | 2.5 | HCC | No |
22 | 69 | Female | S8 | Cranial | HBV | No | 5.50% | 105 | 50 | 8 | 3 | ICC | No |
23 | 47 | Female | S8 | Cranial | - | No | 2.60% | 190 | 50 | 12 | 1.1, 0.7 | Angiomyolipoma | No |
24 | 76 | Female | S8 | Cranial | HBV | Yes | 16% | 158 | 200 | 8 | 2.3 | HCC | No |
25 | 68 | Male | S8 | Caudual | HBV | Yes | 6.50% | 235 | 50 | 26 | 7.5 | HCC | No |
26 | 57 | Female | S8 | Caudual | HBV | Yes | 3.70% | 213 | 100 | 9 | 2.7 | HCC | No |
27 | 42 | Female | S8 | Caudual | - | No | 0.40% | 186 | 1000 | 9 | 5 | HCC | No |
28 | 68 | Male | S8 | Cranial | HBV | Yes | 4.80% | 200 | 100 | 10 | 3.3 | HCC | No |
29 | 38 | Male | S8 | Caudual | HBV | Yes | 5.00% | 195 | 300 | 8 | 2.5 | HCC | Subphrenic collection |
30 | 60 | Male | S8 | Caudual | HBV | Yes | 2.00% | 230 | 200 | 7 | 3.5 | HCC | No |
31 | 47 | Male | S8 | Cranial | - | No | 3.70% | 105 | 50 | 7 | 1.4 | HCC | No |
32 | 72 | Male | S8 | Cranial | HBV | Yes | 6.30% | 165 | 200 | 7 | 1.7 | HCC | No |
33 | 60 | Male | S8 | Caudual | HBV | No | 4.30% | 274 | 500 | 10 | 9 | HCC | No |
34 | 48 | Male | S8d | Cranial | HBV | No | 3.10% | 152 | 50 | 7 | 2.5 | HCC | No |
- Citation: Peng JX, Li HL, Ye Q, Mo JQ, Wang JY, Liu ZY, He JM. Laparoscopic anatomical SVIII resection via middle hepatic fissure approach: Caudal or cranio side. World J Gastrointest Surg 2024; 16(12): 3685-3693
- URL: https://www.wjgnet.com/1948-9366/full/v16/i12/3685.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i12.3685